Hepatic Slug epigenetically promotes liver lipogenesis, fatty liver disease, and type 2 diabetes
Open Access
- 1 June 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 130 (6), 2992-3004
- https://doi.org/10.1172/jci128073
Abstract
De novo lipogenesis is tightly regulated by insulin and nutritional signals to maintain metabolic homeostasis; excessive lipogenesis induces lipotoxicity, leading to nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes. Genetic lipogenic programs have been extensively investigated, but epigenetic regulation of lipogenesis is poorly understood. Here, we identified Slug as an important epigenetic regulator of lipogenesis. Hepatic Slug levels were markedly upregulated in mice by either feeding or insulin treatment. In primary hepatocytes, insulin stimulation increased Slug expression, stability, and interactions with epigenetic enzyme lysine-specific demethylase-1 (Lsd1). Slug bound to the fatty acid synthase (Fasn) promoter where Slug-associated Lsd1 catalyzed H3K9 demethylation, thereby stimulating Fasn expression and lipogenesis. Ablation of Slug blunted insulin-stimulated lipogenesis; conversely, overexpression of Slug, but not a Lsd1 binding-defective Slug mutant, stimulated Fasn expression and lipogenesis. Lsd1 inhibitor treatment also blocked Slug-stimulated lipogenesis. Remarkably, hepatocyte-specific deletion of Slug inhibited the hepatic lipogenic program and protected against obesity-associated NAFLD, insulin resistance, and glucose intolerance in mice. Conversely, liver-restricted overexpression of Slug, but not the Lsd1 binding-defective Slug mutant, had the opposite effects. These results unveil an insulin/Slug/Lsd1/H3K9 demethylation lipogenic pathway that promotes NAFLD and type 2 diabetes.Funding Information
- National Institutes of Health (DK094014)
- National Institutes of Health (DK114220)
- National Institutes of Health (DK115646)
- American Diabetes Association (1-18-IBS-189)
This publication has 45 references indexed in Scilit:
- Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repressionProceedings of the National Academy of Sciences of the United States of America, 2012
- Diacylglycerol Activation of Protein Kinase Cε and Hepatic Insulin ResistanceCell Metabolism, 2012
- Slug and Sox9 Cooperatively Determine the Mammary Stem Cell StateCell, 2012
- Lipocalin 13 Protein Protects against Hepatic Steatosis by Both Inhibiting Lipogenesis and Stimulating Fatty Acid β-OxidationOnline Journal of Public Health Informatics, 2011
- TNFalpha up‐regulates SLUG via the NF‐kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell‐like phenotypeJournal of Cellular Physiology, 2010
- The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1The EMBO Journal, 2010
- Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesisProceedings of the National Academy of Sciences of the United States of America, 2010
- Slug suppression induces apoptosis via Puma transactivation in rheumatoid arthritis fibroblast-like synoviocytes treated with hydrogen peroxideExperimental & Molecular Medicine, 2010
- Prevention of Hepatic Steatosis and Hepatic Insulin Resistance by Knockdown of cAMP Response Element-Binding ProteinCell Metabolism, 2009
- A Role of DNA-PK for the Metabolic Gene Regulation in Response to InsulinCell, 2009